A similar occurrence was seen in dermatomyositis, where the presence of anti-NXP2 and anti-transcription intermediary factor-1 gamma aAb correlated with cancer development right before or after dermatomyositis onset [79,116]. Here, TRIM24 is linked to dermatomyositis.